In adults, RRP is most often diagnosed in the third or fourth decades of life, although, a second peak has been reported around 60 years of age
There isnt much risk in taking it, as studies have demonstrated no side effects for most people
Click to read the study in The Lancet Relevant Reading: Once-Weekly Semaglutide in Adults with Overweight or Obesity In-depth [randomized-controlled trial]: Between Sept 13 and Nov 22, 2021, 709 patients were screened for eligibility across 50 outpatient clinics in 9 countries
However, there are many confounding factors in the process of a 10-year investigation
PLoS One (2015) 10(5):e0126003
Personalized GLP-1 Plans for Thyroid Patients at PlexusDx PlexusDx serves all 50 states without insurance requirements or membership fees, offering compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan and tirzepatide at $289/mo month-to-month, or from $249/mo on the 6-month plan through licensed 503A compounding pharmacies
